TABLE 7.
Total GHG emissions generated by the asthma pathway and number of asthma patients in 2022 and over 2022–2031
| Emissions (t CO2e) by pathway stage and impact | Year 2022 | Period 2022–2031 |
|---|---|---|
| Total emissions | 807 212 | 5 069 706 |
| Primary care usage | 39 032 | 394 826 |
| HCP visits for diagnosis | 5550 | 55 504 |
| Annual reviews | 29 994 | 303 980 |
| Unplanned GP visits | 3487 | 35 342 |
| Medications (controller and reliever inhalers) | 758 717 | 4 579 019 |
| Controller inhaler | 458 178 | 2 746 442 |
| Reliever inhaler | 300 539 | 1 832 577 |
| OCS | 0 | 0 |
| Reliever inhalers in secondary care | 0.03 | 0.32 |
| Add-on medications | 0 | 0 |
| Secondary care stage | 7424 | 75 240 |
| Secondary care intervention | 7424 | 75 240 |
| Patient travelling | 2039 | 20 622 |
| Patient travel to diagnosis | 327 | 3271 |
| Patient travel to annual reviews | 1519 | 15 394 |
| Patient travel to unplanned GP visits | 193 | 1957 |
| Number of patients (millions) | ||
| Total | 3.61 | 36.57 |
| Controlled | 2.16 | 21.91 |
| Uncontrolled | 1.31 | 13.31 |
| Severe | 0.13 | 1.35 |
GHG: greenhouse gas; GP: general practitioner; HCP: healthcare professional; OCS: oral corticosteroids; t CO2e: tonnes of CO2 equivalent.